Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to $214.7 million.

  • Myriad Genetics' Goodwill & Intangibles fell 6414.5% to $214.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.7 million, marking a year-over-year decrease of 6414.5%. This contributed to the annual value of $548.7 million for FY2024, which is 1384.83% down from last year.
  • As of Q3 2025, Myriad Genetics' Goodwill & Intangibles stood at $214.7 million, which was down 6414.5% from $221.7 million recorded in Q2 2025.
  • Myriad Genetics' 5-year Goodwill & Intangibles high stood at $888.2 million for Q1 2021, and its period low was $214.7 million during Q3 2025.
  • Its 5-year average for Goodwill & Intangibles is $596.0 million, with a median of $632.4 million in 2022.
  • As far as peak fluctuations go, Myriad Genetics' Goodwill & Intangibles surged by 591.14% in 2023, and later plummeted by 6414.5% in 2025.
  • Over the past 5 years, Myriad Genetics' Goodwill & Intangibles (Quarter) stood at $643.3 million in 2021, then grew by 3.61% to $666.5 million in 2022, then fell by 4.44% to $636.9 million in 2023, then decreased by 13.85% to $548.7 million in 2024, then crashed by 60.87% to $214.7 million in 2025.
  • Its Goodwill & Intangibles stands at $214.7 million for Q3 2025, versus $221.7 million for Q2 2025 and $543.8 million for Q1 2025.